Literature DB >> 3117235

Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.

F de Wolf1, J Goudsmit, D A Paul, J M Lange, C Hooijkaas, P Schellekens, R A Coutinho, J van der Noordaa.   

Abstract

One hundred and ninety eight men seropositive for human immunodeficiency virus (HIV) antibody and 58 HIV antibody seroconverters were studied for an average of 19.3 (SEM 0.5) months to assess the relation between HIV antigenaemia and the risk of developing the acquired immune deficiency syndrome (AIDS) and AIDS related complex. Forty (20.2%) of the 198 HIV antibody seropositive men were antigen positive at entry and remained so during follow up. Eight (13.8%) of the 58 HIV antibody seroconverters and 20 (12.7%) of the remaining 158 HIV antibody seropositive men became antigen positive during follow up, resulting in an end point attack rate for HIV antigenaemia of 14.3%. AIDS related complex was diagnosed in 25 (15.8%) of the HIV antigen negative men and in 14 (20.7%) of the HIV antigen positive men. AIDS was diagnosed in 15 men, resulting in an end point attack rate for AIDS of 23.9% in the HIV antigen positive group and 1.3% in the antigen negative group. HIV antibody seropositive men without symptoms but with persistent HIV antigenaemia are at increased risk of developing AIDS and AIDS related complex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117235      PMCID: PMC1248742          DOI: 10.1136/bmj.295.6598.569

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  20 in total

1.  Calculation of survival rates for cancer.

Authors:  J BERKSON; R P GAGE
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-05-24

2.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals.

Authors:  J A Levy; J Shimabukuro
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  A computer program for comparing K samples with right-censored data.

Authors:  E T Lee; M M Desu
Journal:  Comput Programs Biomed       Date:  1972-11

4.  HTLV-III infection associated with glandular-fever-like illness in a haemophiliac.

Authors:  J Tucker; C A Ludlam; A Craig; I Philp; C M Steel; R S Tedder; R Cheingsong-Popov; M F Macnicol; D B McClelland; F E Boulton
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

5.  Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation.

Authors:  K Schwartz; B R Visscher; R Detels; J Taylor; P Nishanian; J L Fahey
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

6.  Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.

Authors:  H W Jaffe; P M Feorino; W W Darrow; P M O'Malley; J P Getchell; D T Warfield; B M Jones; D F Echenberg; D P Francis; J W Curran
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

7.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.

Authors:  J M Lange; R A Coutinho; W J Krone; L F Verdonck; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

8.  Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members.

Authors:  J J Goedert; R J Biggar; S H Weiss; M E Eyster; M Melbye; S Wilson; H M Ginzburg; R J Grossman; R A DiGioia; W C Sanchez
Journal:  Science       Date:  1986-02-28       Impact factor: 47.728

Review 9.  Human T-lymphotropic retroviruses.

Authors:  F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

10.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

View more
  30 in total

Review 1.  Clinical, virological and immunological features of primary HIV-1 infection.

Authors:  M D de Jong; H J Hulsebosch; J M Lange
Journal:  Genitourin Med       Date:  1991-10

Review 2.  The clinical prognosis of HIV-1 infection: a review of 32 follow-up studies.

Authors:  G S Cooper; D J Jeffers
Journal:  J Gen Intern Med       Date:  1988 Nov-Dec       Impact factor: 5.128

3.  Antigen detection in primary HIV infection.

Authors:  M von Sydow; H Gaines; A Sönnerborg; M Forsgren; P O Pehrson; O Strannegård
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-23

4.  HIV-1 P24 antigenaemia does not predict time of survival in AIDS patients.

Authors:  J W Mulder; P Krijnen; J Goudsmit; J K Schattenkerk; P Reiss; J M Lange
Journal:  Genitourin Med       Date:  1990-06

5.  Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.

Authors:  G Villa; D Monteleone; C Marra; A Bartoli; A Antinori; F Pallavicini; E Tamburrini; I Izzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

6.  Biological significance of the antibody response to HIV antigens expressed on the cell surface.

Authors:  J Goudsmit; K Ljunggren; L Smit; M Jondal; E M Fenyö; M Jonda
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 7.  Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Authors:  F Kamali
Journal:  Clin Investig       Date:  1993-05

8.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.

Authors:  C A Lee; A N Phillips; J Elford; G Janossy; P Griffiths; P Kernoff
Journal:  BMJ       Date:  1991-11-02

9.  Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

Authors:  D R Henrard; S Wu; J Phillips; D Wiesner; J Phair
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M Tersmette; R E de Goede; B J Al; I N Winkel; R A Gruters; H T Cuypers; H G Huisman; F Miedema
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.